Acorda Therapeutics reported $11.32M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 49.56M 3.56M
Amgen AMGN:US $ 1637M 147M
Anika Therapeutics ANIK:US $ 17.33M 4.01M
Biogen BIIB:US $ 511.8M 52.1M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Clovis Oncology CLVS:US $ 9.64M 0.03M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2822M 303M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Insmed INSM:US $ 10.84M 993K
Ligand Pharmaceuticals LGND:US $ 30.59M 22.44M
Mannkind MNKD:US $ 9.93M 2.32M
Merck MRK:GR € 1813M 92M
Moderna Inc MRNA:US 750M 557M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Teva Pharmaceutical TEVA:IT 1.99B 2M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M